ID: ALA4215405

Max Phase: Preclinical

Molecular Formula: C28H31ClN4O2

Molecular Weight: 491.04

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H]1CN(C)[C@H]2Cc3c([nH]c4ccccc34)/C(=N/N=C\c3cccc(Cl)c3)C[C@H]1[C@H]2C(=O)OC

Standard InChI:  InChI=1S/C28H31ClN4O2/c1-4-18-16-33(2)25-14-22-20-10-5-6-11-23(20)31-27(22)24(13-21(18)26(25)28(34)35-3)32-30-15-17-8-7-9-19(29)12-17/h5-12,15,18,21,25-26,31H,4,13-14,16H2,1-3H3/b30-15-,32-24+/t18-,21+,25-,26+/m0/s1

Standard InChI Key:  GKYWWVWRZPDQJT-VGUNFYMSSA-N

Associated Targets(Human)

Multidrug resistance-associated protein 1 2587 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

ATP-binding cassette sub-family G member 2 4927 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BHK-21 725 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

NIH3T3 5395 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 491.04Molecular Weight (Monoisotopic): 490.2136AlogP: 5.34#Rotatable Bonds: 4
Polar Surface Area: 70.05Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.57CX Basic pKa: 8.46CX LogP: 5.02CX LogD: 3.92
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.30Np Likeness Score: 0.23

References

1. Paterna A, Khonkarn R, Mulhovo S, Moreno A, Madeira Girio P, Baubichon-Cortay H, Falson P, Ferreira MU..  (2018)  Monoterpene indole alkaloid azine derivatives as MDR reversal agents.,  26  (2): [PMID:29233614] [10.1016/j.bmc.2017.11.052]

Source